Different types of upper extremity exercise training in Duchenne muscular dystrophy: Effects on functional performance, strength, endurance, and ambulation

Muscle and Nerve

Volumn 51, Issue 5, 2015, Pages 697-705

  Alemdaroğlu, Ipek ^a   Karaduman, Ayşe ^b   Yilmaz, Öznur Tunca ^b   Topaloğlu, Haluk ^b  

^a BEZMIALEM VAKIF UNIVERSITY   (Turkey)

^b HACETTEPE UNIVERSITY   (Turkey)

Author keywords

Duchenne muscular dystrophy; Endurance; Exercise; Function; Upper extremity

Indexed keywords

STEROID;

ARM MOVEMENT; ARTICLE; CHILD; CLINICAL ARTICLE; CONTROLLED STUDY; DUCHENNE MUSCULAR DYSTROPHY; ELBOW FLEXION; ENDURANCE; ERGOMETER; EXERCISE; FUNCTIONAL PERFORMANCE; GRIP STRENGTH; HUMAN; MOBILIZATION; MUSCLE STRENGTH; PHYSICAL ACTIVITY, CAPACITY AND PERFORMANCE; PHYSIOTHERAPIST; PRIORITY JOURNAL; RANGE OF MOTION; SCHOOL CHILD; ARM; COMPARATIVE STUDY; EXERCISE TEST; HAND STRENGTH; JOINT CHARACTERISTICS AND FUNCTIONS; KINESIOTHERAPY; MALE; MUSCULAR DYSTROPHY, DUCHENNE; PATHOPHYSIOLOGY; PHYSIOLOGY; PROCEDURES; RANDOMIZED CONTROLLED TRIAL; SKELETAL MUSCLE; TIME; TREATMENT OUTCOME; WALKING;

CHILD; EXERCISE; EXERCISE TEST; EXERCISE THERAPY; HAND STRENGTH; HUMANS; MALE; MUSCLE STRENGTH; MUSCLE, SKELETAL; MUSCULAR DYSTROPHY, DUCHENNE; PHYSICAL ENDURANCE; RANGE OF MOTION, ARTICULAR; TIME FACTORS; TREATMENT OUTCOME; UPPER EXTREMITY; WALKING;

EID: 84928214116     PISSN: 0148639X     EISSN: 10974598     Source Type: Journal    
DOI: 10.1002/mus.24451     Document Type: Article

References (44)

1. Biggar WD, Harris VA, Eliasoph L, Alman B. Long-term benefits of deflazacort treatment for boys with Duchenne muscular dystrophy in their second decade. Neuromuscul Disord 2006;16:249-255.
2. Hoffman EP, Brown RH, Kunkel LM. Dystrophin: the protein product of the Duchenne muscular dystrophy locus 1987. Biotechnology 1992;24:457-466.
3. Kanagawa M, Toda T. The genetic and molecular basis of muscular dystrophy: roles of cell-matrix linkage in the pathogenesis. J Hum Genet 2006;51:915-926.
4. Bartels B, Pangalila RF, Bergen MP, Cobben NA, Stam HJ, Roebroeck ME. Upper limb function in adults with Duchenne muscular dystrophy. J Rehabil Med 2011;43:770-775.
5. Jansen M, de Groot IJ, van Alfen N, Geurts A. Physical training in boys with Duchenne muscular dystrophy: the protocol of the No Use is Disuse Study. BMC Pediatr 2010;10:55.
6. Bendixen RM, Lott DJ, Senesac C, Mathur S, Vandenborne K. Participation in daily life activities and its relationship to strength and functional measures in boys with Duchenne muscular dystrophy. Disabil Rehabil 2014;36:1-6.
7. Markert CD, Case LE, Carter GT, Furlong PA, Grange RW. Exercise and Duchenne muscular dystrophy: where we have been and where we need to go. Muscle Nerve 2012;45:746-751.
8. Pellegrini N, Pelletier A, Orlikowski D, Lolierou C, Ruquet M, Raphael JC, et al. Hand versus mouth for call-bell activation by DMD and Becker patients. Neuromuscul Disord 2007;17:532-536.
9. Pellegrini N, Guillon B, Prigent H, Pellegrini M, Orlikovski D, Raphael JC, et al. Optimization of power wheelchair control for patients with severe Duchenne muscular dystrophy. Neuromuscul Disord 2004;14:297-300.
10. Mayhew A, Mazzone ES, Eagle M, Duong T, Ash M, Decostre V, et al. Development of the Performance of the Upper Limb module for Duchenne muscular dystrophy. Dev Med Child Neurol 2013;55:1038-1045.
11. Aboussouan LS. Mechanisms of exercise limitation and pulmonary rehabilitation for patients with neuromuscular disease. Chron Respir Dis 2009;6:231-249.
12. Bushby K, Finkel R, Birnkrant DJ, Case LE, Clemens PR, Cripe L, et al. Diagnosis and management of Duchenne muscular dystrophy, part 2: implementation of multidisciplinary care. Lancet Neurol 2010;9:177-189.
13. Wade CK, Forstch J. Exercise and Duchenne muscular dystrophy. J Neurol Phys Ther 1996;20:20-23.
14. Vry J, Schubert IJ, Semler O, Haug V, Schönau E, Kirschner J. Whole-body vibration training in children with Duchenne muscular dystrophy and spinal muscular atrophy. Eur J Paediatr Neurol 2014;18:140-149.
15. Markert CD, Ambrosio F, Call JA, Grange RW. Exercise and Duchenne muscular dystrophy: toward evidence-based exercise prescription. Muscle Nerve 2011;43:464-478.
16. Rocco AB, LeValley JC, Eldridge JA, Marsh SA, Rodgers BD. A novel protocol for assessing exercise performance and dystropathophysiology in the mdx mouse. Muscle Nerve 2014, doi: 10.1002/mus.24184.
17. Jansen M, van Alfen N, Geurts AC, de Groot IJ. Assisted bicycle training delays functional deterioration in boys with Duchenne muscular dystrophy: the randomized controlled trial "no use is disuse. Neurorehabil Neural Repair 2013;27:816-827.
18. Huijben ALC, Jansen M, Ginjaar HB, Lammers M, Putten M, Alfen N, et al. What can we learn from an assisted bicycle training in a symptomatic girl with Duchenne muscular dystrophy? A case study. Neuromuscul Disord 2013;23:778.
19. Guglieri M, Bushby K. Recent developments in the management of Duchenne muscular dystrophy. J Paediatr Child Health 2011;21:501-509.
20. Brooke MH, Griggs RC, Mendell JR, Fenichel GM, Shumate JB, Pellegrino RJ. Clinical trial in Duchenne dystrophy. I. The design of the protocol. Muscle Nerve 1981;4:186-197.
21. Marchesi C, Main M, Kinali M, Muntoni F. Correlation of hand-held myometry with alternative methods of assessment of muscle strength and function in DMD patients. Abstr Neuromuscul Disord 2008;18:724-833.
22. Turner N, Ferguson K, Mobley BW, Riemann B, Davies G. Establishing normative data on scapulothoracic musculature using handheld dynamometry. J Sport Rehabil 2009;18:502-520.
23. Torres C, Moxley RT, Griggs RC. Quantitative testing of handgrip strength, myotonia, and fatigue in myotonic dystrophy. J Neurol Sci 1983;60:157-168.
24. Kurillo G, Zupan A, Bajd T. Force tracking system for the assessment of grip force control in patients with neuromuscular diseases. Clin Biomech (Bristol, Avon) 2004;19:1014-1021.
25. Ingemar SJ, Merkies AB, Faber CG. Outcome measures in Duchenne muscular dystrophy: are we ready fort he new therapeutic era? Neuromuscul Disord 2009;19:447.
26. Moxley RT. Functional testing. Muscle Nerve 1990;13:26-29.
27. The Complete Minnesota Dexterity Test examiner's manual. Lafayette, IN: Lafayette Instrument Co.; 1991.
28. Mazzone E, Martinelli D, Berardinelli A, Messina S, D'Amico A, Vasco G, et al. North Star Ambulatory Assessment, 6-minute walk test and timed items in ambulant boys with Duchenne muscular dystrophy. Neuromuscul Disord 2010;20:712-716.
29. McDonald CM, Abresch RT, Carter GT, Fowler WM Jr, Johnson ER, Kilmer DD, et al. Profiles of neuromuscular diseases. Duchenne muscular dystrophy. Am J Phys Med Rehabil 1995;74:70-92.
30. Hayran M, Hayran M. Sağlik Araştirmalari için Temel I˙statistik. Art Ofset Matbaacilik Yayincilik Organizasyon; Ltd.; Ankara; 2011 [in Turkish].
31. Hsu JD, Quinlivan R. Scoliosis in Duchenne muscular dystrophy (DMD). Neuromuscul Disord 2013;23:611-617.
32. Yilmaz Ö, Karaduman A, Topaloğlu H. Prednisolone therapy in Duchenne muscular dystrophy prolongs ambulation and prevents scoliosis. Eur J Neurol 2004;11:541-544.
33. Pardo AC, Do T, Ryder T, Meyer A, Miles L, Wong BL. Combination of steroids and ischial weight-bearing knee ankle foot orthoses in Duchenne's muscular dystrophy prolongs ambulation past 20 years of age-a case report. Neuromuscul Disord 2011;21:800-802.
34. Rao S. Question 2: Do steroids prolong ambulation and improve quality of life in children with Duchenne muscular dystrophy? Arch Dis Child 2012;97:1000-1002.
35. Barnes MP, Good DC. Rehabilitation of the muscular dystrophies. Neurological rehabilitation. Handb Clin Neurol 2013;110:471.
36. Straub V. Standards of care in neuromuscular fields. BMC Musculoskel Dis 2013;14:O12.
37. Mazzone ES, Messina S, Vasco G, Main M, Eagle M, D'Amico A, et al. Reliability of the North Star Ambulatory Assessment in a multicentric setting. Neuromuscul Disord 2009;19:458-461.
38. Mattar FL, Sobreira C. Hand weakness in Duchenne muscular dystrophy and its relation to physical disability. Neuromuscul Disord 2008;18:193-198.
39. Wagner MB, Vignos PJ Jr, Carlozzi C. Duchenne muscular dystrophy: a study of wrist and hand function. Muscle Nerve 1989;12:236-244.
40. Zupan A. Assessment of the functional abilities of the upper limbs in patients with neuromuscular diseases. Disabil Rehabil 1996;18:69-75.
41. Lowes LP, Alfano LN, Smigelsi J, Mendell JR, Flanigan KF. SP 11 Development of a virtual upper extremity assessment tool for individuals with DMD across the lifespan. Neuromuscul Disord 2012;22:878-879.
42. Kurillo G, Han JJ, Abresch RT, Nicorici A, Yan P, Bajcsy R. Development and application of stereo camera-based upper extremity workspace evaluation in patients with neuromuscular diseases. PloS One 2012;7:e45341.
43. Mazzone ES, Vasco G, Palermo C, Bianco F, Galluccio C, Ricotti V, et al. A critical review of functional assessment tools for upper limbs in Duchenne muscular dystrophy. Dev Med Child Neurol 2012;54:879-885.
44. Grange RW, Call JA. Recommendations to define exercise prescription for Duchenne muscular dystrophy. Exerc Sport Sci Rev 2007;35:12-17.